S 2198
Prescription Drug Supply Chain Pricing Transparency Act
Take action
Record your position on this measure.
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed Senate
- Passed House
- To President
- Became Law
Bill overview
This bill directs the Government Accountability Office (GAO) to conduct a comprehensive study of how prices are handled within the prescription drug supply chain. The study will examine various compensation and payment structures used by different entities involved, including pharmacy benefit managers, drug wholesalers, and manufacturers. The GAO will analyze potential conflicts of interest and trends in these practices, and ultimately provide Congress with recommendations for potential legislation or administrative changes to increase transparency.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Cosponsor
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.